In the last few decades, we have witnessed the great advances of molecular self-assembly
in biomedical applications. Among the building blocks for molecular self-assembly, peptide …

Bacterial infection is a serious threat to human health and is one of the main causes of death
worldwide. The discovery of antibiotics is considered a great milestone in the history of …

Rheumatoid arthritis (RA) is a chronic, prevalent, immune-mediated, inflammatory, joint
disorder affecting millions of people worldwide. Despite current treatment options, many …

Rheumatoid arthritis (RA), a systemic autoimmune disease that dramatically affects patients'
quality of life. Given the intricacy of RA's pathophysiology, no single treatment can …

Raloxifene, a benzothiophene derivative, was approved for the treatment of breast cancer in
2007 by the US Food and Drug Administration. Herein, we designed a statistically optimized …

Rheumatoid Arthritis (RA) is an autoimmune disorder that hinders the normal functioning of
bones and joints and reduces quality of human life. Every year millions of people are …

Advancing therapeutic effectiveness through the strategic co‐delivery of drugs in a
sequential manner represents a compelling strategy. However, achieving precise and …

The development of injectable, dual-component formulations based on natural-based
polysaccharides is a promising strategy for the localized treatment of rheumatoid arthritis …

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease primarily driven by
inappropriate infiltration and activation of immune cells and pro-inflammatory cytokines …

TNF-α is a key inflammatory cytokine in the progression of rheumatoid arthritis (RA), which is
the most common inflammatory joint disorder and is characterized by persistent synovitis …